跳至主要内容
临床试验/NCT04559061
NCT04559061已完成不适用

Clinical Validation of the Vektor Computational ECG Mapping System (vMap™) for Atrial and Ventricular Arrhythmias/Pacing

Vektor Medical4 个研究点 分布在 1 个国家目标入组 225 人开始时间: 2020年12月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
225
试验地点
4
主要终点
Rate of accuracy/agreement of vMap™ in correctly identifying the ventricular chamber/region of the arrhythmia for PCV and VT.

研究概览

简要总结

This is a retrospective, multi center clinical study collecting existing, de-identified subject data from medical records to be analyzed using an independent core laboratory to validate performance of a computational ECG mapping system (vMap™).

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Retrospective

入排标准

年龄范围
22 Years 至 100 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient has one of the following clinical arrhythmia/pacing types:
  • Atrial pacing
  • Atrial fibrillation
  • Ventricular pacing
  • Premature ventricular complex
  • Ventricular tachycardia
  • Ventricular fibrillation
  • Focal atrial tachycardia
  • Premature atrial complex
  • Atrioventricular reentrant tachycardia
  • Patient has undergone 'successful' routine, standard of care diagnostic electrophysiology (EP) study using intracardiac catheters as clinically indicated, guided by fluoroscopy and routine electroanatomic mapping, intracardiac echocardiography, and/or cardiac imaging such as CT or MRI.
  • Patient has 12 lead electrogram data of clinical rhythms recorded on electrogram recording system.
  • Patient has undergone a successful ablation procedure.
  • Arrhythmia type and atrial/ventricular characteristics can be abstracted from patient medical records.
  • Patient was between 22 and 100 years of age at time of EP study and ablation procedure.

排除标准

  • Patients with unstable coronary artery disease, confirmed intracardiac thrombus, active sepsis, complex congenital heart disease, dextrocardia, severe pulmonary hypertension, decompensated heart failure, a mechanical heart valve, myocardial infarction within 1 month of ablation, inability to induce arrhythmia, unacceptable ECG data quality, and/or data included in the device training dataset.

结局指标

主要结局

Rate of accuracy/agreement of vMap™ in correctly identifying the ventricular chamber/region of the arrhythmia for PCV and VT.

时间窗: Immediately post ablation procedure through approximately 6 months post ablation procedure, based on retrospective data collection eligibility criteria.

次要结局

  • Rate of accuracy/agreement of vMap™ in correctly identifying the chamber/region of the arrhythmia location for all arrhythmia types.(Immediately post ablation procedure through approximately 6 months post ablation procedure, based on retrospective data collection eligibility criteria.)
  • Rate of accuracy/agreement of vMap™ in correctly identifying the segment of the arrhythmia treatment across all arrhythmia types.(Immediately post ablation procedure through approximately 6 months post ablation procedure, based on retrospective data collection eligibility criteria.)

研究者

发起方
Vektor Medical
申办方类型
Industry
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验